A61P 11/08
Bronchodilators
A61P11/08 (Bronchodilators) appears on 3,316 US grants and 4,316 published applications in this corpus.
Search patents in A61P- Granted patents
- 3,316
- Published applications
- 4,316
- Assignees
- 1,307
- Inventors
- 8,507
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 15 | 0 |
| 1978 | 11 | 0 |
| 1979 | 8 | 0 |
| 1980 | 11 | 0 |
| 1981 | 13 | 0 |
| 1982 | 13 | 0 |
| 1983 | 23 | 0 |
| 1984 | 17 | 0 |
| 1985 | 20 | 0 |
| 1986 | 33 | 0 |
| 1987 | 35 | 0 |
| 1988 | 28 | 0 |
| 1989 | 30 | 0 |
| 1990 | 34 | 0 |
| 1991 | 42 | 0 |
| 1992 | 39 | 0 |
| 1993 | 25 | 0 |
| 1994 | 34 | 0 |
| 1995 | 41 | 0 |
| 1996 | 32 | 0 |
| 1997 | 45 | 0 |
| 1998 | 44 | 0 |
| 1999 | 60 | 0 |
| 2000 | 42 | 0 |
| 2001 | 50 | 22 |
| 2002 | 65 | 83 |
| 2003 | 75 | 127 |
| 2004 | 50 | 201 |
| 2005 | 64 | 252 |
| 2006 | 81 | 221 |
| 2007 | 81 | 226 |
| 2008 | 96 | 255 |
| 2009 | 136 | 339 |
| 2010 | 148 | 361 |
| 2011 | 167 | 322 |
| 2012 | 246 | 315 |
| 2013 | 245 | 238 |
| 2014 | 212 | 232 |
| 2015 | 161 | 195 |
| 2016 | 140 | 169 |
| 2017 | 130 | 148 |
| 2018 | 113 | 120 |
| 2019 | 72 | 95 |
| 2020 | 77 | 92 |
| 2021 | 65 | 75 |
| 2022 | 35 | 50 |
| 2023 | 36 | 60 |
| 2024 | 29 | 53 |
| 2025 | 30 | 38 |
| 2026 | 13 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ensifentrine for decreasing the frequency/severity of COPD exacerbations15 Sep 2026US 12,734,139 B2Verona Pharma PLC
- N-(pyridin-2-yl)-6,7,8,9-tetrahydro-5h-5,8-epiminocyclohepta[c]pyridine-10-carboxamide derivatives and similar compounds as GPR65 modulators for the treatment of cancer9 Jun 2026US 12,649,744 B2Pathios Therapeutics Limited
- Fused tri-cyclic compound as a PDE3/PDE4 dual inhibitor2 Jun 2026US 12,643,897 B2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Stabilized receptor polypeptides and uses thereof19 May 2026US 12,630,608 B2Amgen Inc.
- 4-((6-oxopyrimidin-1(6H)-yl)methyl)benzoic acid as an inducer of Z A1AT secretion for treating AATD12 May 2026US 12,624,008 B2Centessa Pharmaceuticals (UK) Limited
- Inhaled statins as bronchodilators to improve lung function in respiratory diseases8 Oct 2026US 2026/0306477 A1Beth Israel Deaconess Medical Center, Inc.
- Galpha12 inhibitors and methods using same10 Sep 2026US 2026/0265220 A1Rutgers, The State University of New Jersey
- High-potency biased beta-2 adrenergic receptor agonist for treating respiratory diseases27 Aug 2026US 2026/0248801 A1University of South Florida
- Nbd1 modulators and methods of using the same20 Aug 2026US 2026/0242373 A1Genzyme Corporation
- Nbd1 modulators and methods of using the same20 Aug 2026US 2026/0242388 A1Genzyme Corporation
Most cited
By later US patents
- Controlled release powder and process for its preparation660US 5,354,556 AElan Corporation, plc · 1994
- Controlled release bases for pharmaceuticals383US 4,861,598 AEuroceltique, S.A. · 1989
- Controlled release powder and process for its preparation333US 4,952,402 AElan Corporation, plc · 1990
- 1H-imidazo[4,5-c]quinolines and their use as bronchodilating agents310US 4,698,348 ARiker Laboratories, Inc. · 1987
- Methods and devices for treating plumonary vasoconstriction and asthma251US 5,485,827 AThe General Hospital Corporation · 1996